Kalaris Therapeutics, Inc. (KLRS)
Market Closed
3 Jun, 20:00
NASDAQ (NMS) NASDAQ (CM) Primary NASDAQ (NMS) $
4. 7200
+0.07
+1.51%
$
87.9M Market Cap
- P/E Ratio
- Div Yield
45,544 Volume
-1.75 Eps
$ 4.65
Previous Close Want to track KLRS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
KLRS Earnings Reports FAQ
What is the earnings per share (EPS) for KLRS?
The current EPS is -1.75.
What is the company's earnings growth rate?
Kalaris Therapeutics, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Kalaris Therapeutics, Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Kalaris Therapeutics, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for KLRS at this time, as Kalaris Therapeutics, Inc has no recent EPS data to calculate it.
